{Reference Type}: Journal Article
{Title}: Controversies in prostate cancer screening.
{Author}: Obiora D;Orikogbo O;Davies BJ;Jacobs BL;
{Journal}: Urol Oncol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 9
{Factor}: 2.954
{DOI}: 10.1016/j.urolonc.2024.06.022
{Abstract}: Prostate cancer is the second most diagnosed cancer and the fifth leading cause of cancer death among men worldwide. In the 1980s, the development and implementation of Prostate-Specific Antigen (PSA) testing for diagnosing prostate cancer led to a surge in the number of prostate cancer diagnoses. We explore the trends in recommendations and new innovations in adjunctive testing for prostate cancer screening.